


The Fund aims to achieve long-term capital growth through investment in North American securities using a value based investment philosophy.
| Name | % Net Assets |
|---|---|
| Merck & Co | 2.7% |
| Goldman Sachs | 2.7% |
| Morgan Stanley | 2.7% |
| Occidental Petroleum | 2.7% |
| Chevron | 2.6% |
| Comcast | 2.6% |
| Wells Fargo | 2.6% |
| Pfizer | 2.6% |
| Morgan Stanley | 2.6% |
| Hewlett Packard | 2.5% |
| Key | % Net Assets |
|---|---|
| 2.7% | |
| 2.7% | |
| 2.7% | |
| 2.7% | |
| 89.2% |
| Date | 09-Nov-2018 |
|---|---|
| NAV | 18.57p |
| Currency | GBP |
| Change | 0.17p |
| % | 0.94% |
| YTD change | 18.57p |
| YTD % | n/a |
| Fund Inception | 01/07/2005 |
|---|---|
| Fund Manager | Richard Brody |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research